Extensive documentation has validated the role of UV irradiation as a tumor initiator and promoter, inducing both squamous and basal cell carcinomas. Human epidermis is a tissue which undergoes active metabolism of arachidonic acid to prostaglandins which is regulated by the action of prostaglandin H synthase (also known as cyclooxygenase). One mechanism for the promotional activity of UV light may involve its ability to induce prostaglandin formation. Work in our laboratory has demonstrated that acute exposure of human keratinocytes to UVB irradiation results in increased production of prostaglandin E 2 (PGE 2 ). When cultured human keratinocytes were examined after irradiation with 30 mJ/cm 2 UVB in vitro, Western blot analysis showed a 6-fold increase in COX-2 protein which was evident at 6 h and peaked 24 h after irradiation. Furthermore, when human subjects were irradiated on sun-protected skin with up to four times their minimal erythema dosage (MED) and biopsied 24 h later, upregulation of COX-2 protein expression was observed via immunofluorescence microscopy. RNAase protection assays supported this observation, showing induction of COX-2 message which peaked at~12 h following irradiation in vitro. Furthermore, human squamous cell carcinoma biopsies exhibited strongly enhanced staining for COX-2 protein via immunohistochemistry and Western analysis when compared to normal non-sun-exposed control skin. Together, these data demonstrate acute upregulation of COX-2 via UVB irradiation and suggest the need for further studies of COX-2 expression as a potential pharmacological target mediating human skin tumor development.
Introduction
Chronic sun exposure is a well-recognized etiologic agent for skin cancer. Approximately 90% of the estimated 900 000-1 200 000 new cases of squamous and basal cell carcinomas diagnosed in the US each year are attributable to UV light exposure. The majority of these tumors are basal cell carcin-omas which are relatively benign, however squamous cell carcinoma (the second most common cutaneous malignancy) accounts for~2000 deaths annually. Extensive documentation has validated the role of ultraviolet B irradiation (UVB*) (290-320 nm) as both a tumor initiator and promoter (1) (2) (3) (4) . One possible mechanism for the promotional activity of UV light involves its ability to induce prostaglandin formation. Increased production of free arachidonic acid and prostaglandins are characteristic responses of human keratinocytes following acute exposure to UVB irradiation (5) (6) (7) (8) . These products may then function as tumor promoters in UV-initiated tissue or they may enhance initiation because of their ability to function as oxidants (9, 10) .
Prostaglandins are formed by the dual action of a phospholipase which releases arachidonic acid from cellular membrane phospholipids and cyclooxygenase (COX) which converts arachidonic acid to prostaglandins (11) . Presently, there are two cyclooxygenase enzymes which have been identified in humans (60% homology): cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). Previous research suggests that COX-1 is a housekeeping gene which modulates physiologic responses such as regulation of renal and vascular homeostasis, and gastroprotection of the stomach. By comparison, COX-2 is primarily an immediate early gene whose synthesis can be stimulated rapidly and transiently in response to tumor promoters (12) , IL-1β (13) , endotoxins (14) , and serum (15) . Recent observations in knockout mice, however, suggest that long-standing dogma regarding the functions of COX-1 and COX-2 may be oversimplified (16) .
Human epidermis actively synthesizes prostaglandins and previous studies have demonstrated that prostaglandin E 2 (PGE 2 ) generation can regulate epidermal cell proliferation in vitro (17) . Prostaglandins generated by the arachidonic acid cascade have been implicated in various models for tumorigenesis. Elevated levels of PGE 2 have been observed in squamous and basal cell carcinomas of the skin and may correlate with an increased propensity for metastatic and invasive behavior (9, 18) .
The importance of prostaglandins in tumorigenesis is evidenced by data demonstrating the ability of various inhibitors of prostaglandin production to inhibit growth and metastasis of tumors in vivo (19) (20) (21) . Most notably, recent epidemiological studies have shown that non-steroidal anti-inflammatory drugs (NSAIDS) which directly inhibit cyclooxygenase reduce the risk of colorectal cancer (22) . The putatitive role of eicosanoids as viable tumor promoters is further suggested by the recent work of Oshima et al. (23) in APC knockout mice (a model for familial adenomatous polyposis) bred with mice expressing wild type or disrupted COX-2 genes. Their work has clearly demonstrated the role of COX-2 as an early rate-limiting step in the pathway from colon polyps to cancer (23, 24) . Additional studies have illustrated that pharmacological intervention by NSAIDS can prolong the lag phase of chemically-induced colon cancer and decrease the polyp number in Min mice (25) .
Moreover, Tsujii and DuBois (26) demonstrated that cells overexpressing COX-2 were resistant to apoptosis, therefore providing a putative mechanism for the ability of NSAIDS to induce apoptosis and subsequently inhibit tumorigenesis (26) .
In the context of skin tumorigenesis, chemical carcinogenesis models have implicated the role of prostaglandins in mediating tumor promotion (27) . Unfortunately however, these studies do not employ agents with clear physiological implications for humans. Studies on skin cancer in humans are often limited to epidemiological data for self-evident reasons. This study explores the effects of acute UVB irradiation in humans and combines these data with in vitro studies of human keratinocytes to demonstrate the role of cyclooxygenase in mediating prostaglandin upregulation in response to irradiation. Furthermore, the long term effects of repetitive UV exposure are elucidated by evaluation of cyclooxygenase expression in squamous cell skin cancer as well as in actinic keratoses, the precursor dysplastic skin lesions which precede the development of squamous cell carcinoma. Collectively, in the context of data currently available, our observations may not only suggest a role for COX-2 expression in responsivity to acute UV irradiation but also further implicate its role as a potential pharmacological target for intervention in skin tumorigenesis.
Materials and methods

Cell culture and preparation of primary human keratinocytes
Primary adult human keratinocyte cultures were obtained from human epidermis removed during reductive mammoplasty and panniculectomies as described previously (28) . The tissue was defatted and the epidermis was separated from the dermis following overnight incubation in 0.25% trypsin. Epidermal cells were then scraped in DMEM (Gibco BRL, Gaithersburg, MD) containing 5% fetal bovine serum, penicillin (5 units/ml), streptomycin (5 µg/ml) and 2.5 mM N-2-hydroxyethypiperazine-NЈ-2-ethanesulfonic acid (HEPES; pH 7.4). Isolated cells are then plated onto type I collagen-coated petri dishes at a density of 7.5ϫ10 5 cells/cm 2 and used at 2-3 days postconfluence.
Irradiation of human keratinocyte cultures
Cultured keratinocytes were exposed to a bank of eight Westinghouse FS-20 bulbs which emit light predominantly in the UVB range, 290-320 nm. Irradiance was measured at 1 mW/cm 2 at a 30 cm distance measured by a UVX-digital radiometer with a UVX 31 filter. Human keratinocyte cultures were irradiated with 30 mJ/cm 2 UV light Irradiation of human subjects and skin biopsy Following institutional approval and informed consent, human volunteers who sunburn easily were recruited for irradiation and biopsy studies. After initial screening to eliminate those who took aspirin-like drugs, and/or photosensitizing medications, these subjects were exposed to varying doses of UV light which would approximate (0.5ϫ, 1ϫ, 2ϫ, and 4ϫ) their individual minimal erythema dose. After a 24 h time period, 6-mm punch biopsies were taken from irradiated and non-irradiated sites. Relative erythema (redness) was surveyed by a Minolta chromameter and biopsies were frozen in optimal cutting temperature compound (OCT) (Miles Inc., Elkhart, IN) immediately after collection and analyzed for COX-2 expression by immunofluorescence microscopy.
Protein determination and Western blot analysis
Confluent cultures of human keratinocytes were scraped and sonicated in buffer containing: 50 mM Tris-HCl, 10% glycerol, and 2% SDS in the presence of protease inhibitors leupeptin (5 µg/ml), pepstatin A (1 µg/ml), soybean trypsin inhibitor (50 µg/ml). Lysates were normalized using the BioRad D c Protein Assay Kit (Bio-Rad, Richmond, CA) and diluted in buffer containing: 50 mM Tris-HCl, 10% glycerol, 2% SDS, 100 mM DTT, and 0.1% bromophenol blue. Lysates were electrophoresed on 7.5% SDS-PAGE gels and transferred to nitrocellulose membranes overnight at 30 mA constant current at 4°C. Membranes were blocked for 1 h at room temperature in 5% nonfat dry milk in Tris-buffered saline (TBS-20 mM Tris-HCl, 137 mM NaCl pH 7.6) with 0.1% Tween 20. After blocking, the membrane was incubated overnight with an anti-pGHS-1 monoclonal antibody (1:1000) (Cayman Chemical, Ann Arbor, MI) or a pGHS-2 polyclonal antibody (Oxford Biomedical Research, Oxford, UK) (1:1000) diluted in TBS-Tween containing 1% non-fat dry milk. Membranes were subsequently washed 3ϫ10 min in 0.1% TBS-Tween, incubated in Protein A-HRP (Amersham, Arlington Heights, IL) (1:2000) for 1 h, washed, and visualized by enhanced chemiluminescence (Amersham).
Assessment of cyclooxygenase activity and PGE 2
The levels of PGE 2 in the supernatants from cultured cells were determined by ELISA using a kit obtained from Cayman Chemical (Ann Arbor, MI). Cyclooxygenase activity was determined by incubating intact keratinocytes for 15 min at 37°C with 30 µM arachidonic acid substrate prior to removal of supernatant for PGE 2 
Immunohistochemistry
Biopsy samples were embedded in OCT (Miles Inc., Elkhart, IN) and serially sectioned at a thickness of 6 µM onto positively charged slides. After warming to room temperature, the slides were immersed in acetone for 10 min at -20°C and allowed to air dry followed by 2ϫ5 min washes in PBS. Nonspecific binding sites were blocked for 20 min at room temperature in buffer containing 1% BSA, 0.2% non-fat milk, 0.3% Triton X-100, and 20% donkey serum diluted in PBS. Sections were incubated overnight in a humidified chamber at 4°C in primary antibody against COX-2 at a dilution of 1:1000. The slides were then washed with PBS for 2ϫ5 min and incubated in CY-3 conjugated donkey anti-rabbit secondary antibody (Jackson Immunochemicals, West Grove, PA) for 30 min at 37°C in a humidified chamber. Finally, slides were washed 3ϫ5 min in PBS followed by a final rinse in distilled water prior to mounting in FluorSave (Calbiochem, San Diego, CA) and visualization by fluorescence microscopy.
Frozen tumor biopsies were sectioned, fixed and washed as above, however due to autofluorescence of tumor sections, a light microscopic alkaline phosphatase method was utilized. Specifically, endogenous avidin/biotin sites were blocked using an avidin/biotin blocking kit as described by the manufacturer (Zymed Immunochemicals, San Francisco, CA). Sections were permeabilized by incubation for 30 min in PBS containing 1% BSA, 0.2% non-fat milk, 0.3% Triton X-100, and 0.2% saponin. Sections were blocked in PBS containing 10% normal goat serum (Sigma, St Louis, MO) for 30 min, then incubated in anti-COX-2 at a dilution of 1:1000 overnight at 4°C. The following day, slides were washed 3ϫ5 min in PBS and a biotinylated goat anti-rabbit secondary antibody (Zymed Immunochemicals, San Francisco, CA) was applied for 1 h at room temperature. Slides were washed 3ϫ5 min in PBS followed by incubation with a streptavidin-alkaline phosphatase conjugate (Shandon-Lipshaw, Pittsburgh, PA) for 45 min. Immunoreactive complexes were detected by a Vector Red substrate (Vector Laboratories, Burlingame, CA) and counterstained using a 50:50 mixture of methyl green and alcian blue in 1% sodium acetate buffer, mounted in GVA (Zymed Immunochemicals), and visualized by light microscopy.
RNAase protection assay
Confluent keratinocyte monolayers were washed three times with PBS, lysed in 4 M guanidine containing 0.72% beta-mercaptoethanol, and extracted in phenol/chloroform. Nucleic acids were precipitated with isopropanol and the concentration was determined by absorbance at 260 nm. Integrity of the RNA was checked by agarose gel electrophoresis and ethidium bromide staining. RNAase protection assays were performed using a kit (Ambion, Austin, TX). Briefly, 5 µg of total RNA from each condition was allowed to hybridize with an antisense RNA probe for COX-1 or COX-2 overnight at 45°C. Subsequently, each condition was treated with RNAase A, ethanol precipitated, and loaded on to an 8 M urea polyarcrylamide gel which was subsequently fixed and dried with overnight exposure to X-ray film at -80°C.
Results
UVB irradiation enhances cyclooxygenase activity
Our laboratory has previously characterized the early time course for the effect of UVB irradiation on prostaglandin synthesis in human keratinocytes. These data illustrated that synthesis and activation of a high-molecular weight calciumdependent cytosolic phospholipase A 2 (cPLA 2 ) mediated PGE 2 production during the first 6 h following irradiation (29) . As shown in Figure 1A , PGE 2 production begins to upregulate at early time points following irradiation and synthesis plateaus between 10 and 24 h post-injury. Furthermore, cyclooxygenase activity increases by~3-fold by 24-h post injury and therefore contributes to enhanced prostaglandin synthesis ( Figure 1B) . These data suggest that the increase in cyclooxygenase activity may temporally follow the increase in cPLA 2 activity previously described to occur at early time points after UV irradiation. This increase in cyclooxygenase activity coupled with an enhancement in prostaglandin production has been observed consistently in a variety of keratinocyte preparations derived from multiple individuals with varying skin types.
Expression of COX-2 protein in UVB irradiated human keratinocytes
Human keratinocyte lysates were collected from cells harvested at control, 6-and 24-h following UVB irradiation in the presence and absence of serum. Similar experiments were performed in the absence or presence of 20 µM dexamethasone. This dose of dexamethasone was determined to completely inhibit IL-1 stimulated COX-2 induction in fibroblasts (data not shown). The blots were probed with a COX-1 monoclonal or a COX-2 polyclonal antibody. COX-1 expression was unaffected by UVB irradiation. Densitometry of the resulting bands indicated an approximate 6-fold increase in COX-2 protein at the 24 h time point which appeared to correlate with the increased PGE 2 production discussed above. Dexamethasone treatment only modestly inhibited (Ͻ50%) COX-2 induction ( Figure 2 ). These findings may reflect the inability of dexamethasone to effectively inhibit the cyclooxygenase-2 enzyme found in human keratinocytes. In order to further verify these results, studies were undertaken to assess inhibition of cyclooxygenase activity utilizing a specific COX-2 inhibitor.
Inhibition of UVB induced cyclooxygenase activity
Further evidence for the role of COX-2 upregulation mediating prostaglandin production was provided by the use of a COX-2 selective inhibitor (SC-58125). The pharmacological profile for SC-58125 inhibition of PGE 2 synthesis indicates that prostaglandin synthesis is COX-2 dependent at 24 h post UVB irradiation. Furthermore, SC-58125 (10 µM) was able to completely inhibit cyclooxygenase activity at a dose selective for COX-2 (IC 50 ϭ 0.09 µM). Similarly, indomethacin (0.1 µM), a non-selective cyclooxygenase inhibitor, was able to completely inhibit activity (Figure 3 ). These data further confirm the specificity for COX-2 upregulation following UVB irradiation of human keratinocytes in culture.
Expression of COX-2 mRNA in irradiated cultured human keratinocytes
Increased COX-2 protein in irradiated keratinocytes suggested that UV irradiation induced synthesis of COX-2. The expression of COX-2 mRNA was therefore evaluated by RNAase protection. Enhanced COX-2 message was observed as early as 6 h post-irradiation. Densitometric analysis indicates an approximate 12-fold induction in COX-2 mRNA at the 12 h time point following irradiation. In contrast, COX-1 mRNA was unaffected by UVB-irradiation (Figure 4) .
Immunohistochemical analysis of COX-2 in UVB irradiated human skin
In order to demonstrate evidence for similar regulation of COX-2 expression in an in vivo model, human subjects were irradiated with doses of UVB ranging between 0.5-4 times the minimal erythema dose (MED) exposure. Staining for COX-2 was minimal in unirradiated tissue but was enhanced in a dose dependent manner in experimental biopsies. As Fig. 3 . SC-58125 (COX-2 specific inhibitor) completely blocks UVBirradiation induced enhancement of cyclooxygenase activity. Post-confluent human keratinocytes were irradiated and supernatants were assayed for PGE 2 production by ELISA following incubation with the specified dosages of either indomethacin or SC-58125. Overlying epidermis from squamous cell carcinoma (C) anti-COX-1, (E) anti-COX-2. Immunoreactive COX-2 expression was identified within tumor nests of SCC (F) and surrounding blood vessels (H). By comparison, blood vessels from normal skin did not express significant COX-2 staining (G). Actinic keratoses, precursor lesions to squamous cell carcinoma, also exhibit enhanced staining for COX-2 (I) when compared to normal skin (D).
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shown in Figure 5 , no staining is present in the control biopsy. However, at four times the MED, COX-2 localization is specific to the epidermis and could be competed fully in the presence of 100-fold excess of COX-2 recombinant protein (data not shown).
Immunohistochemical analysis of COX-2 in actinic keratoses and human squamous cell carcinomas
Epithelial tissues from squamous and basal cell carcinomas, actinic keratoses, as well as normal tissues were evaluated for immunoreactive COX-2 (as denoted by the red staining shown in Figure 6 ). Consistent with the human explant data, immunostaining for COX-2 was usually minimal in normal skin, with subtle expression within regions of differentiated epidermis. By comparison, squamous cell carcinomas exhibited strongly enhanced positive staining in the overlying epidermis (adjacent to chronically sun-exposed skin) and within regions of distinct tumor involvement. Staining was also evident in inflammatory mononuclear cells as well as vascular endothelial cells and hair follicles. These findings are consistent with observations made by Leong et al. (28) . Immunoreactive COX-2 was localized to the overlying epidermis of the squamous cell carcinomas as well as the tumor nests, macrophages, blood vessel endothelia, hair follicles, sebaceous glands, and sweat glands. Basal cell carcinomas biopsies (data not shown) exhibited less intense staining of the overlying epidermis as well as attenuated staining of the tumor islands. Normal human skin demonstrated minimal COX-2 staining within regions of more differentiated epidermis and distinctly positive staining for COX-2 within the sebaceous glands. COX-1 expression was uniformly present within both normal human skin and squamous cell carcinoma biopsies. Most interestingly, actinic keratoses (sun-exposure induced precursor lesions to squamous cell carcinoma) also exhibited prominent COX-2 staining which permeated the full thickness of the epidermis. Increased COX-2 expression observed in squamous cell tumors was further confirmed by Western analysis of frozen tumor specimens ( Figure 7 ).
Discussion
Two elements are necessary for PGE 2 synthesis: i) phospholipase A 2 which controls the availability of free arachidonic acid substrate and ii) cyclooxygenase activity which metabolizes this substrate to available prostaglandins. We have previously demonstrated the role of cytosolic phospholipase A 2 in mediating erythema and PGE 2 formation at early time points following UVB injury (29) . The work described in this study investigates the role of COX-2 as an important enzyme mediating PGE 2 synthesis in response to acute UVB irradiation in human epidermal keratinocytes. COX-2 protein induction occurs~24 h following irradiation in tissue culture and in human in vivo models. This upregulation in total protein is matched with a concurrent enhancement in total prostaglandin production, cyclooxygenase activity, and COX-2 message. Furthermore, the upregulation of cyclooxygenase activity in UVB stimulated keratinocytes is efffectively inhibited by the COX-2 selective Volunteers were irradiated with dosages of UVB approximating 0-4ϫ their MED and were subsequently biopsied after 24 h for documentation of COX-2 expression by immunohistochemistry. Frozen blocks of full-thicknes skin were cut into 6-µm sections and stained for COX-2 expression with a specific polyclonal antibody and analyzed by immunofluorescence microscopy. inhibitor, SC-58125. The data described in this paper clearly demonstrate cyclooxygenase induction in human epidermal UVB injury. Furthermore, this report demonstrates that squamous cell skin cancer, much like colon cancer development, may be linked with chronic activation of the prostaglandin biosynthetic pathway resulting from recurrent UVB exposure.
In the series of tumor biopsies evaluated, COX-2 was prominently expressed in squamous cell carcinomas within the overlying sun-exposed epidermis as well as within the tumor nests. Positive staining was also observed within the endothelium and smooth muscle layers of the blood vessels and infiltrative macrophages of SCC biopsies. Clearly the main source of prostaglandin generation in these tumors appeared to be resulting from the keratinocytes themselves. By comparison, basal cell carcinomas demonstrated very minimal immunoreactive staining for COX-2 within the tumor nests. These data were also confirmed by Western analysis of the tumor biopsies. As has been reported in the case of colon carcinomas stained for COX-2 expression, COX-2 induction is not present in all squamous cell biopsies (present in~70% of biopsies studied), therefore it may not be the only mediator of tumorigenesis. In fact, COX-2 expression may more directly be correlated with tumor aggressivity (30) . The results of the data presented in this report correlate well with observations described by Leong et al. (28) . However, by comparison, the data reported here attempt to link upregulated cyclooxygenase expression with chronic UVB irradiation as an important factor involved in the development of skin carcinoma.
Actinic keratoses are considered to be precursor lesions to squamous cell carcinomas which result from chronic exposure to sunlight. When these biopsies were stained for immunoreactive COX-2, they too exhibited increased staining for COX-2 when compared to normal epidermis (although with markedly less intensity than the SCC biopsies). By inclusion of immunohistochemial staining of biopsies from normal skin, actinic keratosis, and squamous cell carcinoma (SCC), it is evident that increased COX-2 expression is an early event that is present even in precursor dysplastic lesions which precede the development of SCC. Furthermore, these findings provide evidence that chronic UVB irradiation may exacerbate COX-2 expression in vivo. These data may further suggest that COX-2 activation is increased prior to the development of overt malignancy and may therefore play a role in tumor promotion.
Recent clinical studies have provided clear evidence for the role of COX-2 in the mediation of colorectal neoplasia. Epidemiological studies have suggested the capacity of NSAIDS to decrease the incidence of colorectal carcinoma (31, 32) . Similarly, elevated prostaglandin levels have been correlated with higher metastatic potential in human breast cancer (33) (34) (35) . Studies have indicated that skin tumors also have enhanced production of arachidonic acid metabolites (9) suggesting that prostaglandins may also play a role in skin 728 carcinogenesis. Evidence indicates the plausibility of PGE 2 as well as PGF 2α as possible cocarcinogens in chemically-treated mice which develop squamous cell carcinoma. Co-administration of these prostaglandins appears to shorten the latency period to skin tumor formation (36) . Similarly, studies in chemically-initiated mouse models suggest the ability of prostaglandin inhibitors to slow the course of skin tumor progression (27, 37) . Indomethacin treatment in mouse photocarcinogenesis models significantly decreases tumor number (38) . With this evidence in mind, this report directly demonstrates the prevalence of COX-2 in UV-induced human squamous cell carcinoma and its precursor lesion, actinic keratosis.
Current data suggest a model by which UV light injury can function as an initiative stress followed by upregulation of COX-2 which may function in a variety of ways: (i) it may serve to enhance prostaglandin E 2 production which may function as a mitogen in an initiated cell population; (ii) it may inhibit apoptosis (26) and thus promote retention of UVinduced 'sunburn cells' (normally discarded by the epidermis as apoptotic cells); (iii) it may alter the ability of the cells to attach to substrate and thus enhance their propensity to exhibit tumorigenic growth (26) and (iv) it may enhance the formation of DNA adducts or decrease their repair (10, 39) .
The results reported here illustrate the need for evaluation of the potential efficacy of COX-2 selective inhibitors as chemotherapeutic agents to inhibit the course of UV-induced skin cancer. Future studies should combine the use of currently available COX-2 knockout mouse models or overexpression studies to more definitively demonstrate the role of COX-2 in the mediation of photocarcinogenesis in animal models.
